Literature DB >> 6378798

Augmentation of protective and antibacterial activity induced by muramyl dipeptides in CBA/N defective mice with X-linked immunodeficiency for Salmonella enteritidis infection.

K Onozuka, T Saito-Taki, M Nakano.   

Abstract

Stimulation of resistance induced by muramyl dipeptide (MDP) and its analog, N alpha-MDP-N epsilon-stearoyl-L-lysine [MDP-Lys(L18)], was examined in experimental salmonellosis in CBA/N defective mice with X-linked immunodeficiency to virulent Salmonella enteritidis no. 11. An injection of either MDP or MDP-Lys(L18) did not induce any effective protection, but repeated injections of MDP-Lys(L18) (100 micrograms per mouse per day for 3 days consecutively) to the mice before bacterial challenge gave some protection. Multiple injections with MDPs once a day for several days consecutively strongly increased bactericidal capacity in the peritoneal cavities and spleens of the mice. Moreover, previous injection of the MDPs could elevate the phagocytic function of the reticuloendothelial system in the defective mice. These results indicate that nonspecific resistance of CBA/N defective mice to salmonella infection can be improved by previous administrations of MDPs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378798      PMCID: PMC263246          DOI: 10.1128/iai.45.2.424-427.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Susceptibility of CBA/N mice to infection with Salmonella typhimurium: influence of the X-linked gene controlling B lymphocyte function.

Authors:  A D O'Brien; I Scher; G H Campbell; R P MacDermott; S B Formal
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

Review 2.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

Review 3.  The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity.

Authors:  I Scher
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

4.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

5.  Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.

Authors:  L Chedid; M Parant; F Parant; F Audibert; F Lefrancier; J Choay; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

6.  Defective resistance to Plasmodium yoelii in CBA/N mice.

Authors:  K W Hunter; F D Finkelman; G T Strickland; P C Sayles; I Scher
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

7.  Experimental malaria in the CBA/N mouse.

Authors:  A N Jayawardena; C A Janeway; J D Kemp
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

8.  Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice.

Authors:  K Matsumoto; H Ogawa; T Kusama; O Nagase; N Sawaki; M Inage; S Kusumoto; T Shiba; I Azuma
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

9.  Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine.

Authors:  K Matsumoto; T Otani; T Une; Y Osada; H Ogawa; I Azuma
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

10.  Stimulation of nonspecific host resistance to infection induced by muramyldipeptides.

Authors:  K Matsumoto; H Ogawa; O Nagase; T Kusama; I Azuma
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

View more
  3 in total

1.  Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice.

Authors:  N C Phillips; L Chedid
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

2.  Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.

Authors:  P M Melissen; W van Vianen; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

Review 3.  Regulation of Immune Homeostasis via Muramyl Peptides-Low Molecular Weight Bioregulators of Bacterial Origin.

Authors:  Svetlana V Guryanova
Journal:  Microorganisms       Date:  2022-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.